iFlyTek Ventures on Empowering Scientists to Cross the Startup Valley of Death
创业邦 · wechat · 2026-08-11
Following the IPO of CIQTEK, the investment logic of its early backer iFlyTek Ventures has gained attention. Originating from a university lab itself, iFlyTek deeply understands the pain points of commercializing research, positioning itself as a "pacer" for scientist entrepreneurs.
Targeting scientists with both technical depth and entrepreneurial spirit, iFlyTek Ventures addresses their lack of business experience. Beyond capital, it opens up iFlyTek's mature marketing networks and management expertise to help startups cross the valley from lab to market.
Its portfolio now includes dozens of deep-tech firms like Cambricon and Galbot. The firm believes scientists hold an irreplaceable advantage in fundamental tech breakthroughs, making this a golden era for scientist-led startups.
More from Venture
- Fundraising Guide for First-Time Founders: De-risking for VCs — CCgong · 2026-08-11
- Aureka Raises $100M Series B, Open-Sources OpenDDE Drug Discovery Engine — 机器之心 · 2026-08-11
- Sequoia's 20-Year HN Trend Analysis: Short-Term Hype Rarely Breeds Great Companies — FinanceYF5 · 2026-08-11
- AI Startup Dyna Secures Investment Backed by Cracked Research Team — JasonMa2020 · 2026-08-11
- Laid-Off to $1,800/Mo: An Indie SaaS Journey in 19 Days — ayushtweetshere · 2026-08-11
- Anthropic Reportedly Eyes IPO This Fall as Frontier Inference Proves Profitable — toptickcrypto · 2026-08-11